Fiji health authorities are scrambling to stem an outbreak of HIV, as growing meth use and alarming needle-sharing trends accelerate the spread of the virus.
19h
GlobalData on MSNMSD to push for approval of HIV combo after Phase III successMSD’s HIV treatment is now back on track after an earlier hit which saw the FDA place a clinical hold on the therapy.
Dr. Maya Green discusses HIV prevention, addressing racial disparities in healthcare, and the powerful impact of stigma on ...
Gilead Sciences' data on two novel, once-yearly formulations of lenacapavir for PrEP support the further development of the ...
Sciences presented the first data from its ongoing Phase 1 study investigating two novel, once-yearly formulations of ...
The man’s case didn’t give rise to any widespread variant, but it gave Gupta, with his HIV evolution background, the idea ...
13d
Al Jazeera on MSNAfrica HIV deaths to mount, as Trump stops funding. Here’s whyIn a report this week, UNAIDS said at least 55 countries around the world had reported funding cuts to HIV programmes, including several in African countries. That included halts to 55 HIV projects ...
Federal datasets began disappearing from public view on Jan 31, in response to executive orders from President Donald Trump.
cbc.ca on MSN9d
'People will die,' says Canadian charity in Kenya as Trump's USAID cuts threaten HIV medicationsThe Trump administration announced last week that it was cancelling nearly 10,000 foreign aid grants and contracts worth ...
Here’s what to know about how aid cuts to HIV/AIDS programmes are affecting African countries: Schoolgirls pass a mobile clinic, background, run by the Reproductive Health and HIV Institute (RHI ...
In HIV-1-infected patients with extensive drug resistance, the optimization of background antiretroviral therapy is essential when changing drugs after treatment failure. The genotypic sensitivity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results